Rheumatology 2016
 
                     Platinum Sponsors


Pfizer

Pfizer: Working together for Britain's national health.  We are Pfizer, one of the world’s premier innovative biopharmaceutical companies, discovering, developing and providing over 100 different medicines, vaccines and consumer healthcare products that help save and transform the lives of millions of people in the UK and around the world every year.  http://www.pfizer.co.uk/



Roche Products Ltd and Chugai Pharma UK Ltd

As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, Roche contributes on a broad range of fronts to improving people’s health and QOL. Chugai’s mission is to dedicate itself to adding exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health.



Silver Sponsors


       Bristol-Myers Squibb

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb UK aims to deliver on its commitments: to our patients and customers, to our employees, to our communities, and to our environment.




Novartis Pharmaceuticals UK Limited

Novartis Pharmaceuticals UK Limited, is a pharmaceutical company which discovers and develops innovative treatments to cure and prevent disease.  Novartis conducts research into many different disease areas, including Rheumatology.  Building on its heritage as an innovator in healthcare solutions, Novartis Specialty Rheumatology is developing science-driven therapies to redefine treatment paradigms and transform patient care.


Bronze Sponsors

                
Eli Lilly 

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work.




Mallinckrodt Specialty Pharmaceuticals Ireland Ltd

Mallinckrodt Specialty Pharmaceuticals Ireland Ltd. (MSPIL) is a subdivision of the global specialty biopharmaceutical business, Mallinckrodt Pharmaceuticals, which focuses on therapeutic drugs for autoimmune and rare diseases. MSPIL owns the licence for Synacthen and Synacthen® Depot in the UK and in a number of different countries internationally. Synacthen® Depot is indicated for certain autoimmune and inflammatory diseases including acute gout.

   Sobi

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. 


       
UCB

UCB: Inspired by Patients. Driven by Science  UCB, Brussels, Belgium (www.ucbpharma.co.uk) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in approximately 40 countries, the company generated revenue of € 3.3 billion in 2014. UCB is listed on Euronext Brussels (symbol: UCB).


Janssen Pharmaceuticals

At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in immunology, oncology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world.


                        
AbbVie Ltd

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories.  The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.  AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.  For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk.


Celgene Ltd

Celgene is committed to improving the lives of people with immune and inflammatory diseases.  Continuing our mission to find new solutions for under-served conditions, our current inflammation and immunology portfolio includes a treatment for psoriasis and psoriatic arthritis, with a rich and varied pipeline of treatments into a broader range of auto-immune conditions.   Established in the UK & Ireland in 2006, with our headquarters in Stockley Park, Middlesex,  Celgene UK


4S DAWN Clinical Software

DAWN RH is a comprehensive results and follow-up management application to help clinic physicians’ review and track patients in a safe, reliable and efficient manner. Record key scores, measures and patient reported outcomes easily, facilitating paperless working and saving time in searching for historical values for things such as BASMI, DAS28, SLICC, FRAX, PsARC, QRISK2 among others, whilst following best-practice guidelines.

Actelion Pharmaceuticals UK Ltd

Actelion Pharmaceuticals UK Ltd. Actelion focuses on the discovery, development and commercialisation of innovative treatments to serve unmet medical needs. Please visit us on stand 28 in the main Exhibition Hall to find out more.



A.Menarini Farmaceutica Internazionale SRL


Menarini Farmaceutica Internazionale SRL was established in 1999 as the UK affiliate of the Menarini Group– an Italian pharmaceutical company based in Florence with over 16,500 employees. Menarini is one of Europe's leading pharmaceutical and healthcare companies, with headquarters in Florence and research facilities in Pomezia, near Rome. The organisation, which was incorporated over 100 years ago has over forty subsidiaries operating throughout Eastern and Western Europe. We are actively involved in the development of leading edge medicines for cardiovascular disease, pain relief, oncology and Sexual Health with teams supporting Healthcare Professionals across primary care, secondary care and commissioning organisations.

Arthritis Research UK

Arthritis Research UK is the leading authority on arthritis in the UK, funding research into all types of arthritis and related musculoskeletal conditions. We provide information for patients and health care professionals, as well as supporting education and innovation in the promotion of musculoskeletal health. To find out more visit our website www.arthritisresearchuk.org, or come and meet us at stand 8.


buchanan orthotics ltd

Buchanan Orthotics are both a clinical service provider and a manufacturer.  We manufacture the Steprite range of footwear and a full range of bespoke orthotic products in our Glasgow factory.


Cytokine Signalling Forum

Developed under the auspices of the University of Glasgow and with a steering committee of leading rheumatologists the Cytokine Signalling Forum is an online resource providing CME courses, reviews of recent literature and an interactive forum for colleagues to discuss their opinions. Visit our stand or log on to www.cytokinesignaling.com


Cytori Therapeutics, Inc.

Cytori Therapeutics is a clinical-stage cell therapy company developing an autologous adipose-derived cell therapy, ECCS-50, for hand disability in scleroderma patients. The STAR and SCLERADEC-II Phase III clinical trials in the US and France, respectively, are  currently enrolling patients.  Data from preclinical studies and clinical trials suggest that ECCS-50 may act principally by improving blood flow, modulating the immune system, and facilitating wound repair. For more information visit www.cytori.com or stand 36.


Feet and Spine

Specialising in Comfort footwear, Computer Matched Orthotics (insoles), Ergonomic Chairs, Sit-stand tables, Ergonomic aids and Orthopaedic Splints. Helping solve mechanical musculoskeletal issues (aches and pains) without medical or surgical intervention. www.feetandspine.com


Hospira UK Ltd

Hospira is a global speciality pharmaceutical and medication delivery company dedicated to Advancing Wellness™. A leader in speciality injectable pharmaceuticals offering a broad portfolio in acute care and oncology, as well as integrated infusion therapy. Hospira has one of the industry’s largest biosimilar pipelines and is committed to the development of innovative, comparable, cost saving products for the people who need them.



Internis Pharma

Founded in 2010, Internis is a UK speciality pharmaceutical company engaged in the development and commercialisation of highly effective and innovative new medicines aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency.


Intrapharm Laboratories Ltd

Intrapharm Laboratories are pleased to announce the relaunch of Triamcinolone Hexacetonide. This has the longest duration of action and is indicated for intraarticular, intrasynovial or periarticular use in adults and adolescents (3 to 12 years) for the symptomatic treatment of subacute and chronic inflammatory joint diseases.


King’s College London – MSc Rheumatology and TITRATE

The MSc in Rheumatology at KCL is the only one of its type in London. It is a multidisciplinary programme designed to achieve excellence in patient centred care, research and training.  TITRATE, an NIHR-funded Programme Grant for Applied Research, aims to improve outcomes for RA patients with intermediate disease activity. Visit our stand to meet our team and find out more. www.titrate.org.uk.


medac GmbH, UK Branch

medac GmbH is a privately owned German company founded in 1970. medac mainly promotes the development and marketing of the therapeutics in the field of autoimmune diseases and oncology. We endeavour to provide the best quality pharmaceutical products with faultless service in an effective, timely and customer-focused manner


MEDICA Group

MEDICA are the UK’s leading provider of teleradiology services.  MEDICA’s UK remote reporting services have been designed and refined in partnership with more than 80 NHS organisations. MEDICA use NHS doctors with significant experience in DXA reporting, offering full equivalence to an in-house service and providing flexible capacity, all within a stringent quality and support framework.


MSD

MSD operates in more than 140 countries and focuses on prescription medicines, vaccines, biologic therapies, and animal health products. The company is called MSD everywhere, except in the United States and Canada, where we are known as Merck & Co., Inc., Kenilworth, NJ, USA. For more information visiwww.msd-uk.com.



Napp Pharmaceuticals Limited

Napp Immunology is a division of Napp Pharmaceuticals Limited, a UK healthcare company that has been providing high-quality, innovative medicines for over 80 years. We believe in real world, value-based innovation; delivering medicines to the NHS that meet genuine needs and make a positive difference to patients’ lives.


NHS Research Scotland

NHS Research Scotland promotes and supports excellence in clinical and translational research in Scotland so that patients can benefit from new and better treatments. Formed through a partnership of Scottish NHS Boards and the Chief Scientist Office (CSO) of Scottish Government, we work to ensure that NHS Scotland provides the best environment to support clinical research.   www.nrs.org.uk / @NHSResearchScot / communications@nrs.org.uk


Nordic Pharma Ltd

The Nordic Group is a privately-owned, fast-growing, fully-integrated, pan-European group of pharmaceutical companies with a strong emphasis on quality products and services catering to the special needs of each client and patient. The Nordic Group originated in 1995 with the first Nordic organisation in Scandinavia.  Today Nordic focuses on two specialised segments of the pharmaceutical market: Marketing and sales of speciality pharmaceuticals; Specialised pharmaceutical services focussed on product development, manufacturing, supply logistics and regulatory activities.


Oxford University Press

Oxford University Press is a leading publisher in rheumatology journals, books and online products and our worldwide publishing furthers the University's objectives of excellence in scholarship, research, and education. Visit our stand today to pick up a sample copy of Rheumatology, the official journal of the British Society for Rheumatology, and browse our collection of books, available to buy with an exclusive 20% conference discount.


Sandoz

Sandoz, a Novartis company, is committed to increasing patient access to high-quality generics and biosimilars. Sandoz currently markets three biosimilars in Europe, each of which is the market leader for a biosimilar in its respective category. The Sandoz  pipeline includes several biosimilars in various stages of development.


Sanofi

Sanofi and Regeneron are committed to providing resources to better understand and research Rheumatoid Arthritis.


Scope Ophthalmics

Scope Ophthalmics (www.scopeophthalmics.com) is an innovative and fast-growing eye care company offering dry eye and blepharitis products in the UK and Ireland. All of its products have had long-term success with patients worldwide. The company maintains a major focus on training, customer service, innovation and relationships with key opinion leaders.


Vasculitis UK

Vasculitis UK is the Uk’s largest vasculitis patient support charity,  offering information, advice and advocacy, covering all aspects of vasculitic disease, for those suffering from all types of systemic vasculitis.  The charity works closely with medical and healthcare professionals to improve knowledge and understanding of vasculitis with a view to improving awareness, recognition, diagnosis and treatment. The charity also supports and funds vasculitis research.


Wisepress Medical Bookshop

Wisepress.com, Europe’s leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending nearly 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.

Alexion

Company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Patients with these life-threatening diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.